Evotec

Evotec

Verified
Drug discovery alliance company providing drug discovery solutions to pharmaceutical and biotechnology companies.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2020202120222023202420252026
Revenues501m618m751m779m881m1.1b1.2b
% growth12 %23 %22 %4 %13 %20 %13 %
EBITDA99.0m94.9m94.2m69.7m149m265m323m
% EBITDA margin20 %15 %13 %9 %17 %25 %27 %
Profit6.3m216m(176m)(55.5m)10.4m73.9m113m
% profit margin1 %35 %(23 %)(7 %)1 %7 %9 %
EV / revenue9.9x11.5x3.3x4.8x1.8x1.5x1.1x
EV / EBITDA50.0x74.8x26.4x54.1x10.5x5.9x4.2x
R&D budget63.9m72.2m76.6m----
R&D % of revenue13 %12 %10 %----

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound

N/A

Spinout

N/A

-
N/A

€600k

Seed

€2.5m

Grant
N/A

N/A

IPO

$40.0m

Post IPO Equity

€40.0m

Post IPO Equity

€90.3m

Post IPO Equity

€75.0m

Post IPO Debt
*

€25.0m

Post IPO Equity
N/A

$23.8m

Grant

€250m

Post IPO Equity
*

$18.0m

Grant
*

€150m

Post IPO Debt
*

$6.6m

Grant
*

$2.5m

Grant
Total Funding€49.4m

Recent News about Evotec

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
KINAXO Biotechnologies
ACQUISITION by Evotec Apr 2011
Just-Evotec Biologics
ACQUISITION by Evotec May 2019
Cell Culture Service GmbH
ACQUISITION by Evotec Jan 2013
Bionamics GmbH
ACQUISITION by Evotec Mar 2014
View 17 more